van Doorn E - Search Results

1

[Effectiveness of influenza vaccine in the Netherlands: predominant circulating virus type and vaccine match are important conditions].

van Doorn E, Darvishian M, Dijkstra F, Bijlsma MJ, Donker GA, de Lange MMA, Cadenau LM, Hak E, Meijer A. van Doorn E, et al. Ned Tijdschr Geneeskd. 2017;161:D1648. Ned Tijdschr Geneeskd. 2017. PMID: 28558853 Dutch.

2

Influenza Vaccine Effectiveness in the Netherlands from 2003/2004 through 2013/2014: The Importance of Circulating Influenza Virus Types and Subtypes.

Darvishian M, Dijkstra F, van Doorn E, Bijlsma MJ, Donker GA, de Lange MM, Cadenau LM, Hak E, Meijer A. Darvishian M, et al. Among authors: van doorn e. PLoS One. 2017 Jan 9;12(1):e0169528. doi: 10.1371/journal.pone.0169528. eCollection 2017. PLoS One. 2017. PMID: 28068386 Free PMC article.

3

Influenza vaccine effectiveness estimates in the Dutch population from 2003 to 2014: The test-negative design case-control study with different control groups.

van Doorn E, Darvishian M, Dijkstra F, Donker GA, Overduin P, Meijer A, Hak E. van Doorn E, et al. Vaccine. 2017 May 15;35(21):2831-2839. doi: 10.1016/j.vaccine.2017.04.012. Epub 2017 Apr 12. Vaccine. 2017. PMID: 28412077 Free PMC article.

4

National Differences in Requirements for Ethical and Competent Authority Approval for a Multinational Vaccine Trial under the EU Directive 2001/20/EC.

van Doorn E, Hak E, Wilffert B. van Doorn E, et al. Vaccines (Basel). 2015 Apr 14;3(2):263-92. doi: 10.3390/vaccines3020263. Vaccines (Basel). 2015. PMID: 26343188 Free PMC article. Review.

5

Safety and tolerability evaluation of the use of Montanide ISA™51 as vaccine adjuvant: A systematic review.

van Doorn E, Liu H, Huckriede A, Hak E. van Doorn E, et al. Hum Vaccin Immunother. 2016;12(1):159-69. doi: 10.1080/21645515.2015.1071455. Epub 2015 Sep 17. Hum Vaccin Immunother. 2016. PMID: 26378866 Free PMC article. Review.

6

Influenza Vaccine Research funded by the European Commission FP7-Health-2013-Innovation-1 project.

Liu H, Frijlink HW, Huckriede A, van Doorn E, Schmidt E, Leroy O, Rimmelzwaan G, McCullough K, Whelan M, Hak E. Liu H, et al. Among authors: van doorn e. Vaccine. 2016 Nov 21;34(48):5845-5854. doi: 10.1016/j.vaccine.2016.10.040. Epub 2016 Oct 25. Vaccine. 2016. PMID: 27793486 Review.

7

Evaluating the immunogenicity and safety of a BiondVax-developed universal influenza vaccine (Multimeric-001) either as a standalone vaccine or as a primer to H5N1 influenza vaccine: Phase IIb study protocol.

van Doorn E, Liu H, Ben-Yedidia T, Hassin S, Visontai I, Norley S, Frijlink HW, Hak E. van Doorn E, et al. Medicine (Baltimore). 2017 Mar;96(11):e6339. doi: 10.1097/MD.0000000000006339. Medicine (Baltimore). 2017. PMID: 28296763 Free PMC article. Clinical Trial.

8

Evaluation of the immunogenicity and safety of different doses and formulations of a broad spectrum influenza vaccine (FLU-v) developed by SEEK: study protocol for a single-center, randomized, double-blind and placebo-controlled clinical phase IIb trial.

van Doorn E, Pleguezuelos O, Liu H, Fernandez A, Bannister R, Stoloff G, Oftung F, Norley S, Huckriede A, Frijlink HW, Hak E. van Doorn E, et al. BMC Infect Dis. 2017 Apr 4;17(1):241. doi: 10.1186/s12879-017-2341-9. BMC Infect Dis. 2017. PMID: 28376743 Free PMC article. Clinical Trial.

9

Prevalence of delayed gastric emptying in diabetic patients and relationship to dyspeptic symptoms: a prospective study in unselected diabetic patients.

Samsom M, Vermeijden JR, Smout AJ, Van Doorn E, Roelofs J, Van Dam PS, Martens EP, Eelkman-Rooda SJ, Van Berge-Henegouwen GP. Samsom M, et al. Among authors: van berge henegouwen gp, van doorn e, van dam ps. Diabetes Care. 2003 Nov;26(11):3116-22. doi: 10.2337/diacare.26.11.3116. Diabetes Care. 2003. PMID: 14578248

10

Preclinical Models of Cardiac Disease: A Comprehensive Overview for Clinical Scientists.

van Doorn ECH, Amesz JH, Sadeghi AH, de Groot NMS, Manintveld OC, Taverne YJHJ. van Doorn ECH, et al. Cardiovasc Eng Technol. 2024 Apr;15(2):232-249. doi: 10.1007/s13239-023-00707-w. Epub 2024 Jan 16. Cardiovasc Eng Technol. 2024. PMID: 38228811 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

34 results

Search Page